Kevin E. Weddington

Array ( [id] => 6687934 [patent_doc_number] => 20030031659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Probiotic, lactic acid-producing bacteria and uses thereof' [patent_app_type] => new [patent_app_number] => 10/264745 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19532 [patent_no_of_claims] => 154 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031659.pdf [firstpage_image] =>[orig_patent_app_number] => 10264745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814145 [patent_doc_number] => 20030073695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Methods of use of gemifloxacin compounds against fluoroquinolone resistant Streptococcus pneumoniae bacteria' [patent_app_type] => new [patent_app_number] => 10/262826 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3144 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073695.pdf [firstpage_image] =>[orig_patent_app_number] => 10262826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688880 [patent_doc_number] => 20030032605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections' [patent_app_type] => new [patent_app_number] => 10/254430 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13048 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032605.pdf [firstpage_image] =>[orig_patent_app_number] => 10254430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688855 [patent_doc_number] => 20030032580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Use of agonists or antagonists of the 5-HT7 receptor to treat disorders of the bladder' [patent_app_type] => new [patent_app_number] => 10/228779 [patent_app_country] => US [patent_app_date] => 2002-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16722 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032580.pdf [firstpage_image] =>[orig_patent_app_number] => 10228779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6651406 [patent_doc_number] => 20030105062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Anti-bacterial agents based upon oxoanion binding' [patent_app_type] => new [patent_app_number] => 10/227327 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5594 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105062.pdf [firstpage_image] =>[orig_patent_app_number] => 10227327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043793 [patent_doc_number] => 06867226 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-15 [patent_title] => 'Serotonin 5-HT3 receptor partial activator' [patent_app_type] => utility [patent_app_number] => 10/219496 [patent_app_country] => US [patent_app_date] => 2002-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12534 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867226.pdf [firstpage_image] =>[orig_patent_app_number] => 10219496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1018011 [patent_doc_number] => 06890905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-10 [patent_title] => 'Methods for improving islet signaling in diabetes mellitus and for its prevention' [patent_app_type] => utility [patent_app_number] => 10/216349 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21432 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890905.pdf [firstpage_image] =>[orig_patent_app_number] => 10216349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 724853 [patent_doc_number] => 07045550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-16 [patent_title] => 'Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy' [patent_app_type] => utility [patent_app_number] => 10/214917 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21410 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045550.pdf [firstpage_image] =>[orig_patent_app_number] => 10214917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537416 [patent_doc_number] => 20020193368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Use of potassium channel openers for the treatment of insulitis' [patent_app_type] => new [patent_app_number] => 10/213725 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3083 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193368.pdf [firstpage_image] =>[orig_patent_app_number] => 10213725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770491 [patent_doc_number] => 20030216431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation' [patent_app_type] => new [patent_app_number] => 10/209837 [patent_app_country] => US [patent_app_date] => 2002-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7372 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216431.pdf [firstpage_image] =>[orig_patent_app_number] => 10209837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721420 [patent_doc_number] => 20030055110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Retinoid compounds suited for antibacterial applications' [patent_app_type] => new [patent_app_number] => 10/207777 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5502 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055110.pdf [firstpage_image] =>[orig_patent_app_number] => 10207777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1101950 [patent_doc_number] => 06815436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-09 [patent_title] => 'Composition and method for the treatment of dysglucaemia' [patent_app_type] => B2 [patent_app_number] => 10/202870 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6971 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815436.pdf [firstpage_image] =>[orig_patent_app_number] => 10202870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236130 [patent_doc_number] => 06689810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-10 [patent_title] => 'Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide' [patent_app_type] => B2 [patent_app_number] => 10/205353 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8855 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689810.pdf [firstpage_image] =>[orig_patent_app_number] => 10205353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262206 [patent_doc_number] => 20020188028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Anti-infective compositions, methods and systems for treating disordered tissue' [patent_app_type] => new [patent_app_number] => 10/200897 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25004 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20020188028.pdf [firstpage_image] =>[orig_patent_app_number] => 10200897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653484 [patent_doc_number] => 20030008905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Method for the improvement of islet signaling in diabetes mellitus and for its prevention' [patent_app_type] => new [patent_app_number] => 10/200870 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7135 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008905.pdf [firstpage_image] =>[orig_patent_app_number] => 10200870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241248 [patent_doc_number] => 06683071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Initiation of oestrus' [patent_app_type] => B1 [patent_app_number] => 10/070783 [patent_app_country] => US [patent_app_date] => 2002-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4344 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/683/06683071.pdf [firstpage_image] =>[orig_patent_app_number] => 10070783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6330075 [patent_doc_number] => 20020198242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Method for the improvement of islet signaling in diabetes mellitus and for its prevention' [patent_app_type] => new [patent_app_number] => 10/196038 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7130 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198242.pdf [firstpage_image] =>[orig_patent_app_number] => 10196038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361971 [patent_doc_number] => 20040014730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Formulations and methods of reducing toxicity of anti-infective agents' [patent_app_type] => new [patent_app_number] => 10/192377 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6702 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014730.pdf [firstpage_image] =>[orig_patent_app_number] => 10192377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716496 [patent_doc_number] => 20030027844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Pharmaceutical compositions for ulcer' [patent_app_type] => new [patent_app_number] => 10/189453 [patent_app_country] => US [patent_app_date] => 2002-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3266 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027844.pdf [firstpage_image] =>[orig_patent_app_number] => 10189453 [rel_patent_id] =>[rel_patent_doc_number] =>)